Major Players Swap Positions Among Industry Top 50
Key Developments Lead To Ups And Downs In The Middle Of Our Ranking
The second part of Generics Bulletin’s newly-compiled global sales ranking of generics and biosimilars companies sees a number of major firms sliding up and down the table.
